About the job
At Olema Oncology, we are committed to pioneering advanced therapies for breast cancer and beyond. Our flagship program, palazestrant (OP-1250), is an innovative complete estrogen receptor antagonist (CERAN) currently undergoing development for metastatic breast cancer, showing significant promise as both a monotherapy and in combination therapy for ER+/HER2- metastatic breast cancer. Additionally, our next candidate, OP-3136, is a leading KAT6 inhibitor with potential to set new standards in treatment.
Our scientific advancements are driven by an environment that encourages fearless support, motivation, and collaboration. At Olema, we believe that prioritizing our team leads to exceptional outcomes. If you are prepared to be part of something transformative, let’s collaborate to create meaningful impacts for our patients, your career, and the future of medicine.
For more insights, view our latest corporate presentations here.
About the Role: Senior Director, Global Regulatory Strategy Lead - Regulatory Affairs
In the position of Senior Director, Global Regulatory Strategy Lead - Regulatory Affairs, reporting to the Senior Vice President of Regulatory Affairs, your key responsibilities will include:
- Leading the development of the New Drug Application (NDA).
- Creating and implementing innovative regulatory strategies that support Olema's product portfolio.
- Acting as the subject matter expert for Regulatory Affairs on cross-functional teams, providing guidance to global project teams, Study Execution Teams, and the Executive Committee.
- Offering strategic and tactical oversight for the development of regulatory submissions, including INDs, CTx, briefing documents, IB, NDA, BLA, DMF, IMPD, etc.
This role is based in either our Boston, MA or San Francisco, CA office and will involve domestic and international travel of up to 20%.
This role will primarily involve:
Leading the NDA development and submission for our lead program
- Formulating innovative global regulatory strategies for the Olema product suite, addressing both clinical development and lifecycle management as required.
- Representing Regulatory Affairs on cross-functional teams as the SME, delivering regulatory guidance and oversight to global project teams, Study Execution Teams, and the Executive Committee.

